Gene Editing

Evaluating immune protection after third and fourth doses of homologous and heterologous SARS-CoV-2 vaccines among kidney transplant recipients

Posted on May 4, 2022 by Editorial Staff

Researchers evaluated the immune responses after the third and fourth doses of homologous and heterologous mRNA vaccines against COVID-19 in kidney transplant recipients.

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='facebook' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/facebook.svg'>

Share on Facebook

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='Twitter' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/Twitter.svg'>

<img style='max-height: 25px;display:unset;margin:0' class='sfsi_wicon' alt='Follow' src='https://thecrisprsociety.com/wp-content/plugins/ultimate-social-media-icons/images/responsive-icon/Follow.png'>

<img alt='' src='https://secure.gravatar.com/avatar/008c46a8d463cb955213048824ccf788?s=90&d=identicon&r=g' srcset='https://secure.gravatar.com/avatar/008c46a8d463cb955213048824ccf788?s=180&d=identicon&r=g 2x' class='avatar avatar-90 photo' height='90' width='90' />

Editorial Staff